Why Are Aidoc’s AI Tools Winning Over Radiologists?
Clinical decision support startup Aidoc has become a major player in healthcare AI thanks to…
Clinical decision support startup Aidoc has become a major player in healthcare AI thanks to its focus on acute, life-or-death cases and its R&D-first approach. As Aidoc continues to innovate, Chief Business Officer Tom Valent thinks its commitment to patient safety and transparency will be key contributors to future success. The post Why Are Aidoc’s…
The shortfalls that accompany this technology gap touch everything from continuity of care and outcomes to the patient experience. The post Mind The Gaps: Closing the Digital Divide to Improve Behavioral Healthcare appeared first on MedCity News.
The proposed models intend to test a payment model that modifies the inflation rebate using international drug pricing information
We’ve automated everything but the one workflow that most directly determines whether patients actually get the care they need. The gap between knowing what works and implementing it at scale reveals the real problem that healthcare treats referrals as an administrative burden to manage, not a critical workflow to optimize. The post The Referral Is…
A look back at some of the most intriguing statements from Healthcare Innovation interviews in the past year
KFF Health News senior correspondent Renuka Rayasam discussed gun violence in Bogalusa, Louisiana, on KALW’s Your Call on Dec. 19. Click here to hear Rayasam on Your Call. Read Rayasam’s “Guns, Race, and Profit: The Pain of America’s Other Epidemic,” co-reported with Fred Clasen-Kelly. KFF Health News rural health correspondent Andrew Jones discussed the implications…
AIAN individuals experience significant health disparities compared to their White counterparts. People who identified as AIAN alone have shorter life expectancies (70.1 vs 78.4 years at birth), higher rates of chronic diseases, and higher rates of suicide deaths and substance use disorder.
Due to a combination of lower coverage rates, additional access barriers, and historical and ongoing discrimination, AIAN people continue to face significant disparities in health and health care.
Kaiser Permanente consolidated 12 EHR instances across California into two in a matter of hours without disrupting patient care. This project has simplified clinical workflows and improved data consistency, as well as provided a rare example of EHR consolidation executed successfully at scale, said Neil Cowles, the health system’s chief information and technology officer. The…
BioMarin Pharmaceutical’s acquisition of Amicus Therapeutics is a marriage of two rare disease biotech companies. Amicus’s two commercialized products, for the enzyme deficiencies Fabry disease and Pompe disease, are each projected to become blockbuster sellers. The post BioMarin’s Presence in Rare Enzyme Disorders Grows With $4.8B Amicus Therapeutics Acquisition appeared first on MedCity News.